Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 43, Issue 31, Pages 2984-2993
Publisher
Oxford University Press (OUP)
Online
2022-06-10
DOI
10.1093/eurheartj/ehac306
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial
- (2021) João Pedro Ferreira et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists
- (2021) Li Shen et al. JACC-Heart Failure
- Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
- (2021) João Pedro Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
- (2021) Brendon L Neuen et al. EUROPEAN HEART JOURNAL
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Major Renal Outcomes in Heart Failure
- (2021) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
- (2021) Yang Xu et al. AMERICAN HEART JOURNAL
- Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
- (2020) Patrick Rossignol et al. EUROPEAN JOURNAL OF HEART FAILURE
- Serum potassium in the PARADIGM‐HF trial
- (2020) João Pedro Ferreira et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
- (2020) Milton Packer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality
- (2019) Joost C. Beusekamp et al. JACC-Heart Failure
- Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
- (2018) Gianluigi Savarese et al. JACC-Heart Failure
- Associations of serum potassium levels with mortality in chronic heart failure patients
- (2017) Mette Aldahl et al. EUROPEAN HEART JOURNAL
- Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality
- (2017) Julio Núñez et al. CIRCULATION
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2016) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Regulation of Potassium Homeostasis
- (2014) B. F. Palmer Clinical Journal of the American Society of Nephrology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search